3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
79
Myelodysplastic Syndromes
42
Leukemia
23
Leukemia, Myelomonocytic, Chronic
20
Congenital Abnormalities
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Recurrence
7
Neoplasms
7
Myeloproliferative Disorders
7
Blast Crisis
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia, Myeloid, Accelerated Phase
5
Carcinoma, Non-Small-Cell Lung
5
Thrombocythemia, Essential
4
Primary Myelofibrosis
4
Polycythemia Vera
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lung Neoplasms
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Burkitt Lymphoma
3
Anemia, Refractory, with Excess of Blasts
3
Anemia, Refractory
3
Small Cell Lung Carcinoma
2
Neuroblastoma
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Interventions
aldesleukin
9
Interleukin-2
9
Nivolumab
7
fludarabine phosphate
6
Dacarbazine
6
Cyclophosphamide
6
fludarabine
5
Temozolomide
4
Ipilimumab
4
Fluorouracil
4
montanide ISA 51
3
Surveys and Questionnaires
3
Semaxinib
3
Radiotherapy
3
Radiation
3
Mohs Surgery
3
Educational Status
3
Cisplatin
3
Allovectin-7
3
zanolimumab
2
talabostat
2
sonidegib
2
poly ICLC
2
binimetinib
2
Whole-Body Irradiation
2
Vinblastine
2
Vemurafenib
2
Tacrolimus
2
Tablets
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Skin Neoplasms
×
Decitabine
×
Clear all
NCT00715793
2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2
Completed
39 enrolled
12 charts